IDENTIFICATION OF HIGHLY ACTIVE DRUG COMBINATIONS FOR THE THERAPY OF NF1-ASSOCIATED MALIGNANT PERIPHERAL NERVE SHEATH TUMORS USING THE ZEBRAFISH MODE
$918,749FY2016Department of the ArmyDOD
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc.